150
Participants
Start Date
April 1, 2024
Primary Completion Date
August 31, 2024
Study Completion Date
August 31, 2024
Meropenem Infusion
"Inclusion Criteria:~* 1 month to 16 years old~* Bacterial Infection (suspected or known) Admitted to PICU with suspected or known bacterial infection~* Prescribed intravenous meropenem~* Informed consent obtained from parent/guardian~Exclusion Criteria:~* Known allergy to carbapenems~* Severe renal impairment (eGFR \< 30 mL/min/1.73 m²)~* Use of other investigational antibiotics at the same time~* Prematurely Terminating the Treatment or Early Discharge Against Medical Advice Age Range: 1 month to 16 years old Gender: BOTH Sample Size (Number of participants): 150"
Pns Shifa Hospital, Karachi., Karachi
Pakistan Navy Station Shifa Hospital
OTHER